The Erenumab Biosimilar Anti-CGRP(R) Antibody offered by Assay Genie is a cutting-edge product designed for research involving the CGRP(R) receptor, a key player in migraine pathophysiology. This biosimilar antibody, derived from advanced biotechnology processes, is highly specific and shows strong binding affinity to the CGRP(R) receptor in human samples.With its validated efficacy in various experimental settings, including cell-based assays and protein analysis techniques, the Erenumab Biosimilar Anti-CGRP(R) Antibody is a powerful tool for investigating the role of CGRP signaling in migraine and other neurological disorders.
Its high sensitivity and precision make it an invaluable asset in drug development and pharmacological research aimed at targeting the CGRP pathway for therapeutic interventions.By providing researchers with a reliable and robust tool for studying CGRP signaling, this biosimilar antibody opens up new avenues for understanding the molecular mechanisms underlying migraine and offers potential insights for the development of novel treatments. Explore the possibilities with the Erenumab Biosimilar Anti-CGRP(R) Antibody from Assay Genie and unlock the secrets of CGRP-mediated pathways in neurological health.
Product Name:
Erenumab (Anti-CGRPR) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0148
Target:
CGRPR
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
AMG 334,AMG-334,erenumab-aooe
Description:
Anti-CGRPR(Erenumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG2
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
